{"id":2946,"date":"2017-08-13T07:38:59","date_gmt":"2017-08-13T07:38:59","guid":{"rendered":"https:\/\/andromedichyperthermia.com\/?page_id=2946"},"modified":"2026-02-17T10:27:04","modified_gmt":"2026-02-17T10:27:04","slug":"andromedic-la-esho-2014","status":"publish","type":"page","link":"https:\/\/andromedichyperthermia.com\/ro\/andromedic-la-esho-2014\/","title":{"rendered":"Andromedic la ESHO 2014"},"content":{"rendered":"<p><script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@graph\": [\n    {\n      \"@type\": \"MedicalWebPage\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/ro\/andromedic-la-esho-2014\/#webpage\",\n      \"url\": \"https:\/\/andromedichyperthermia.com\/ro\/andromedic-la-esho-2014\/\",\n      \"name\": \"Studii clinice cu Andromedic HyDeep 600 WM - Congresul ESHO\",\n      \"description\": \"Date din studiile clinice privind HyDeep 600 WM pentru cancerul de col uterin \u0219i studii de fezabilitate multicentrice prezentate la congresul ESHO.\",\n      \"inLanguage\": \"ro-RO\",\n      \"isPartOf\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#website\" },\n      \"mainEntity\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#hydeep-600wm\" },\n      \"about\": [\n        {\n          \"@type\": \"MedicalStudy\",\n          \"name\": \"Studiul LACC privind carcinomul cervical\",\n          \"description\": \"Studiu pe 8 paciente care indic\u0103 un control local de 100% prin utilizarea sistemului HyDeep 600 WM \u0219i a brahiterapiei HDR.\",\n          \"studySubject\": { \"@type\": \"MedicalCondition\", \"name\": \"Cancer de col uterin\" }\n        },\n        {\n          \"@type\": \"MedicalStudy\",\n          \"name\": \"Studiu caz-control \u00een Spania\",\n          \"description\": \"Studiu de fezabilitate la scar\u0103 larg\u0103 cu 293 de pacien\u021bi cuprinz\u00e2nd 9 localiz\u0103ri tumorale.\",\n          \"sampleSize\": 293,\n          \"studyStatus\": \"Published\"\n        }\n      ],\n      \"mentions\": [\n        { \"@id\": \"https:\/\/andromedichyperthermia.com\/hyperthermia-doctor-salvatore-conte\/\" },\n        { \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\" }\n      ]\n    },\n    {\n      \"@type\": [\"Product\", \"MedicalDevice\"],\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/#hydeep-600wm\",\n      \"name\": \"HyDeep 600WM\",\n      \"brand\": { \"@type\": \"Brand\", \"name\": \"Andromedic\" },\n      \"image\": \"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/HyDeep-600WM-Andromedic.jpg\",\n      \"description\": \"Sistem de hipertermie oncologic\u0103 avansat\u0103 \/ dispozitiv de hipertermie local\u0103 profund\u0103 \/ dispozitiv de hipertermie RF modulat\u0103 (13.56 MHz).\",\n      \"offers\": {\n        \"@type\": \"Offer\",\n        \"price\": \"0\",\n        \"priceCurrency\": \"EUR\",\n        \"availability\": \"https:\/\/schema.org\/InStock\",\n        \"url\": \"https:\/\/andromedichyperthermia.com\/ro\/contact\/\",\n        \"priceSpecification\": {\n          \"@type\": \"PriceSpecification\",\n          \"description\": \"Pre\u021b la cerere\"\n        }\n      },\n      \"review\": {\n        \"@type\": \"Review\",\n        \"author\": { \"@type\": \"Person\", \"name\": \"Dr. med. Veronica Iatan\" },\n        \"reviewRating\": { \"@type\": \"Rating\", \"ratingValue\": \"5\", \"bestRating\": \"5\" },\n        \"reviewBody\": \"Tehnologie de ultim\u0103 genera\u021bie pentru hipertermie profund\u0103, cu protocoale validate clinic.\"\n      }\n    },\n    {\n      \"@type\": \"MedicalOrganization\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\",\n      \"name\": \"Andromedic Srl\"\n    }\n  ]\n}\n<\/script><\/p>\n<div style=\"line-height: 1.6; color: #333; max-width: 1100px; margin: auto; font-family: 'Segoe UI', Helvetica, sans-serif; background-color: #fff; padding: 20px;\">\n<header style=\"border-bottom: 4px solid #1a2a6c; padding-bottom: 25px; margin-bottom: 40px; text-align: center;\">\n<h1 style=\"color: #1a2a6c; font-size: 28px; font-weight: 800; text-transform: uppercase; margin-bottom: 10px;\">Societatea European\u0103 de Oncologie Hipertermic\u0103: <a href=\"http:\/\/esho.info\" target=\"_blank\" rel=\"noopener\">ESHO<\/a> 2014<\/h1>\n<h2 style=\"color: #b21f1f; font-size: 20px; font-weight: 600;\">Interven\u021bia Andromedic \u2013 Dr. Salvatore Conte<\/h2>\n<p style=\"font-size: 16px; max-width: 850px; margin: 15px auto; color: #555;\">\u00cen 2014, producatorul de echipamente de hipertermie <strong>Andromedic<\/strong> a marcat un record industrial \u0219i clinic, livr\u00e2nd 25 de <a href=\"https:\/\/andromedichyperthermia.com\/ro\/dispozitiv-hipertermie-locala-rf-mht\/\">dispozitive hipertermie locala <strong>HyDeep 600 WM<\/strong> <\/a>\u00een doar 18 luni, cu \u00eenc\u0103 40 de unit\u0103\u021bi programate pentru India.<\/p>\n<\/header>\n<div style=\"margin-bottom: 50px; border-radius: 15px; overflow: hidden; box-shadow: 0 10px 25px rgba(0,0,0,0.2);\">\n<p><iframe loading=\"lazy\" title=\"intervento Andromedic   Esho 20014\" width=\"640\" height=\"360\" src=\"https:\/\/www.youtube.com\/embed\/fgMdXxoJ1cI?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/p>\n<\/div>\n<h2 style=\"text-align: center; color: #1a2a6c; margin-bottom: 30px;\">Studii Clinice Hipertermie Prezentate cu dispozitivul de hipertermie HyDeep 600 WM<\/h2>\n<section style=\"margin-bottom: 50px; border: 1px solid #e1e8ed; border-radius: 15px; overflow: hidden; box-shadow: 0 5px 15px rgba(0,0,0,0.05);\">\n<div style=\"background: #1a2a6c; color: #fff; padding: 20px;\">\n<h3 style=\"margin: 0; font-size: 19px;\">1. Chimioradioterapie + Hipertermie Locala Profunda + Brahiterapie \u00een Cancerul Cervical Local Avansat (LACC)<\/h3>\n<\/div>\n<div style=\"padding: 30px; background: #f9f9f9;\">\n<p><strong>SCOPURI:<\/strong> Investigarea rezultatului combinat pentru LACC. Hipertermia locala profunda ad\u0103ugat\u0103 la RT singur\u0103 a demonstrat \u00eembun\u0103t\u0103\u021birea controlului tumoral f\u0103r\u0103 a cre\u0219te toxicitatea de grad 3-4.<\/p>\n<div style=\"background: #fff; padding: 20px; border-radius: 10px; margin: 20px 0; border-left: 5px solid #b21f1f;\">\n<p><strong>MATERIALE \u0218I METODE:<\/strong><\/p>\n<ul style=\"margin-top: 10px; font-size: 15px;\">\n<li><strong>E\u0219antion:<\/strong> 8 paciente (3 stadii IIB, 1 IIIB, 2 NEI, 3 LRCC).<\/li>\n<li><strong>Protocol:<\/strong> Cisplatin s\u0103pt\u0103m\u00e2nal + HT + IMRT (50,4 Gy &#8211; 61,8 Gy SIB) urmat de BRT (21 Gy \u00een 3 frac\u021bii).<\/li>\n<li><strong>Frecven\u021b\u0103 HT:<\/strong> O dat\u0103 pe s\u0103pt\u0103m\u00e2n\u0103.<\/li>\n<\/ul>\n<\/div>\n<div style=\"background: #e8f5e9; padding: 20px; border-radius: 10px; border: 1px solid #2e7d32;\">\n<p><strong style=\"color: #1b5e20; font-size: 17px; display: block; margin-bottom: 10px;\">REZULTATE &amp; CONCLUZII:<\/strong><\/p>\n<p style=\"font-size: 16px; font-weight: bold; margin: 0;\">To\u021bi pacien\u021bii cancer au ob\u021binut CONTROL LOCAL. Zero toxicitate acut\u0103 sau tardiv\u0103 de grad 3-4.<\/p>\n<p style=\"margin-top: 10px; font-style: italic;\">&#8222;Ad\u0103ugarea hipertermiei locale profunde reprezint\u0103 o nou\u0103 strategie promi\u021b\u0103toare \u0219i bine tolerat\u0103.&#8221;<\/p>\n<\/div>\n<\/div>\n<\/section>\n<section style=\"margin-bottom: 50px; border: 1px solid #e1e8ed; border-radius: 15px; overflow: hidden; box-shadow: 0 5px 15px rgba(0,0,0,0.05);\">\n<div style=\"background: #b21f1f; color: #fff; padding: 20px;\">\n<h3 style=\"margin: 0; font-size: 19px;\">2. Studiu de Cvasi-Fezabilitate (Caz-Control) &#8211; Andaluzia, Spania<\/h3>\n<\/div>\n<div style=\"padding: 30px;\">\n<p><strong>Introducere:<\/strong> Primul studiu clinic din Spania\/Andaluzia care integreaz\u0103 hipertermie locala profund\u0103 cu tratamentele standard ( chimioradioterapie) \u00een sistemul public de s\u0103n\u0103tate.<\/p>\n<div style=\"display: grid; grid-template-columns: repeat(auto-fit, minmax(250px, 1fr)); gap: 20px; margin: 25px 0;\">\n<div style=\"background: #f0f4f8; padding: 15px; border-radius: 10px; border-top: 4px solid #1a2a6c;\"><strong>Design Studiului:<\/strong> 293 pacien\u021bi cancer \u00een total (97 \u00eenrola\u021bi activ vs 196 control). 9 loca\u021bii tumorale.<\/div>\n<div style=\"background: #f0f4f8; padding: 15px; border-radius: 10px; border-top: 4px solid #1a2a6c;\"><strong>Protocol Tratament Hipertermie:<\/strong> 10 \u0219edin\u021be (2-3\/s\u0103pt), 1 or\u0103\/\u0219edin\u021b\u0103, putere 150W &#8211; 400W (dispozitiv de hipertermie oncologica avansata Andromedic HyDeep 600WM).<\/div>\n<\/div>\n<h4 style=\"color: #1a2a6c; border-bottom: 2px solid #b21f1f; display: inline-block; padding-bottom: 5px;\">Detalii Date Preliminare (22 pacien\u021bi oncologici):<\/h4>\n<ul style=\"margin-top: 15px; font-size: 14px;\">\n<li><strong>Localiz\u0103ri:<\/strong> Glioblastom, cap \u0219i g\u00e2t, rect preoperator, s\u00e2n, pl\u0103m\u00e2n (NSCLC), prostat\u0103, col uterin, metastaze osoase.<\/li>\n<li><strong>V\u00e2rsta medie:<\/strong> 55 ani. <strong>Supravie\u021buire:<\/strong> 19 pacien\u021bi \u00een via\u021b\u0103 la momentul evalu\u0103rii.<\/li>\n<\/ul>\n<div style=\"display: flex; flex-wrap: wrap; gap: 15px; margin: 25px 0;\">\n<div style=\"flex: 1; min-width: 200px; background: #fffde7; padding: 20px; border-radius: 10px; text-align: center; border: 1px solid #fbc02d;\"><span style=\"font-size: 28px; font-weight: 800; display: block;\">81,2%<\/span><br \/>\n<strong>TOLERAN\u021a\u0102 RIDICAT\u0102<\/strong><br \/>\n<small>Pacien\u021bi mul\u021bumi\u021bi\/foarte mul\u021bumi\u021bi<\/small><\/div>\n<div style=\"flex: 1; min-width: 200px; background: #f1f8e9; padding: 20px; border-radius: 10px; text-align: center; border: 1px solid #7cb342;\"><span style=\"font-size: 28px; font-weight: 800; display: block;\">66,6%<\/span><br \/>\n<strong>ZERO TOXICITATE<\/strong><br \/>\n<small>F\u0103r\u0103 efecte adverse raportate<\/small><\/div>\n<\/div>\n<p style=\"background: #f4f7f9; padding: 15px; border-radius: 8px; border-left: 4px solid #1a2a6c;\"><strong>CONCLUZIE:<\/strong> Tratamentul hipertermie oncologica Andromedic este fezabil \u00een spitalele publice de rutin\u0103, f\u0103r\u0103 resurse extraordinare, oferind confort sporit \u0219i toxicitate u\u0219oar\u0103 (doar 33% cazuri grad 1).<\/p>\n<div style=\"text-align: center; margin-top: 30px;\"><a style=\"display: inline-block; background: #b21f1f; color: #fff; padding: 14px 30px; text-decoration: none; border-radius: 5px; font-weight: 800; text-transform: uppercase; box-shadow: 0 4px 10px rgba(178,31,31,0.3);\" href=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Protocolo-del-ensayo-MAG-HIP-2013-01-11-EN.pdf\">Descarc\u0103 Protocolul Complet (PDF)<\/a><\/div>\n<\/div>\n<\/section>\n<div style=\"margin-top: 40px;\">\n<h3 style=\"text-align: center; color: #1a2a6c; text-transform: uppercase; letter-spacing: 1px;\">Documenta\u021bie \u0218tiin\u021bific\u0103 ESHO<\/h3>\n<div id='gallery-1' class='gallery galleryid-2946 gallery-columns-1 gallery-size-full'><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon portrait'>\n\t\t\t\t<a href=\"https:\/\/andromedichyperthermia.com\/ro\/preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma-2\/\"><img loading=\"lazy\" decoding=\"async\" width=\"590\" height=\"837\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma.jpg\" class=\"attachment-full size-full\" alt=\"\" aria-describedby=\"gallery-1-1339\" srcset=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma.jpg 590w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma-211x300.jpg 211w\" sizes=\"auto, (max-width: 590px) 100vw, 590px\" title=\"\"><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-1339'>\n\t\t\t\tPreliminary results of chemoradiation plus Andromedic hyperthermia and high dose rate brachytherapy for locally advanced cervical carcinoma\n\t\t\t\t<\/figcaption><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon portrait'>\n\t\t\t\t<a href=\"https:\/\/andromedichyperthermia.com\/ro\/quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-b-2\/\"><img loading=\"lazy\" decoding=\"async\" width=\"569\" height=\"831\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-B.jpg\" class=\"attachment-full size-full\" alt=\"\" aria-describedby=\"gallery-1-1318\" srcset=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-B.jpg 569w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-B-205x300.jpg 205w\" sizes=\"auto, (max-width: 569px) 100vw, 569px\" title=\"\"><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-1318'>\n\t\t\t\tQuasi feasibility study(case control) asscoaiting deep local hyperthermia treatment with standard cancer treatments and describing patterns of response ESHO\n\t\t\t\t<\/figcaption><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon portrait'>\n\t\t\t\t<a href=\"https:\/\/andromedichyperthermia.com\/ro\/quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-2\/\"><img loading=\"lazy\" decoding=\"async\" width=\"568\" height=\"826\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response.jpg\" class=\"attachment-full size-full\" alt=\"\" aria-describedby=\"gallery-1-1297\" srcset=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response.jpg 568w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-206x300.jpg 206w\" sizes=\"auto, (max-width: 568px) 100vw, 568px\" title=\"\"><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-1297'>\n\t\t\t\tQuasi feasibility study(case control) asscoaiting deep local hyperthermia HyDeep 600WM treatment with standard cancer treatments and describing patterns of response\n\t\t\t\t<\/figcaption><\/figure>\n\t\t<\/div>\n\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Societatea European\u0103 de Oncologie Hipertermic\u0103: ESHO 2014 Interven\u021bia Andromedic \u2013 Dr. Salvatore Conte \u00cen 2014, producatorul de echipamente de hipertermie Andromedic a marcat un record industrial \u0219i clinic, livr\u00e2nd 25 de dispozitive hipertermie locala HyDeep 600 WM \u00een doar 18 luni, cu \u00eenc\u0103 40 de unit\u0103\u021bi programate pentru India. Studii Clinice Hipertermie Prezentate cu dispozitivul&hellip;<\/p>\n","protected":false},"author":1,"featured_media":17335,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-gutentor-full-width.php","meta":{"footnotes":""},"class_list":["post-2946","page","type-page","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/andromedichyperthermia.com\/ro\/wp-json\/wp\/v2\/pages\/2946","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/andromedichyperthermia.com\/ro\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/andromedichyperthermia.com\/ro\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/ro\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/ro\/wp-json\/wp\/v2\/comments?post=2946"}],"version-history":[{"count":0,"href":"https:\/\/andromedichyperthermia.com\/ro\/wp-json\/wp\/v2\/pages\/2946\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/ro\/wp-json\/wp\/v2\/media\/17335"}],"wp:attachment":[{"href":"https:\/\/andromedichyperthermia.com\/ro\/wp-json\/wp\/v2\/media?parent=2946"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}